Pharmacokinetics of Aminocaproic Acid in Scoliosis Surgery

Completed

Conditions studied: Scoliosis

In brief

This study will evaluate the pharmacokinetics of antifibrinolytic drug epsilon-aminocaproic acid (EACA) in children undergoing Posterior spinal fusion surgery (PSF) at The Children's Hospital of Philadelphia (CHOP) who receive EACA at the standard dose reported in the literature for this population and currently in use at CHOP.

Key facts

Study ID

NCT01408823

Run by

Children's Hospital of Philadelphia

People needed

20

Starts

2011-07-01

Expected to finish

2011-10-01

Last updated by the study team

2013-08-09

Who can join

Age: 8 and older, up to 18. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males or females age 8 to 18 years 2)Subjects undergoing posterior spinal fusion surgery 3)Subjects in whom aminocaproic acid administration is planned by the anesthesiology team 4)Parental/guardian permission (written informed consent) and when appropriate, child assent.

You may not qualify if…

• Wards of the State are not eligible
• Subjects with a history of abnormal renal function -

Where it is running

• The Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.